Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

102.34 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗

September 15, 2024

These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings.

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Exact Sciences ↗

September 12, 2024

Via Benzinga

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 12, 2024

Via Benzinga

Exact Sciences to Participate in September Investor Conferences

August 28, 2024

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Analysts Slash Their Forecasts After Q2 Results ↗

August 01, 2024

Via Benzinga

Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights ↗

July 17, 2024

Via Benzinga

Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts ↗

June 26, 2024

Via Benzinga

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

August 23, 2024

Via AB Newswire

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

August 23, 2024

Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)

Via News Direct

Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study

August 20, 2024

From Exact Sciences Corp.

Via Business Wire

New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion

August 15, 2024

From Exact Sciences Corp.

Via Business Wire

9 Health Care Stocks Whale Activity In Today's Session ↗

August 13, 2024

Via Benzinga

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio? ↗

August 04, 2024

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....

Via Benzinga

Crude Oil Moves Lower; Moderna Shares Plunge ↗

August 01, 2024

Via Benzinga

Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July ↗

August 01, 2024

Via Benzinga

Topics Stocks

Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday ↗

August 01, 2024

Via Benzinga

Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat ↗

August 01, 2024

The company expects stronger second-half sales vs. the first half of 2024.

Via Investor's Business Daily

Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript ↗

August 01, 2024

EXAS earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Exact Sciences Stock Climbs After Strong Q2 Results ↗

July 31, 2024

Exact Sciences shares are trading higher after the company reported its second-quarter financial results Wednesday. Here's a look at the details from the report:

Via Benzinga

Exact Sciences Announces Second-Quarter 2024 Results

July 31, 2024

From Exact Sciences Corp.

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

July 31, 2024

The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions.

Via The Motley Fool

FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption ↗

July 29, 2024

FDA approves Guardant Health's Shield blood test for colorectal cancer screening in adults 45+, marking the first FDA-approved blood test as a primary CRC screening option. Shield meets Medicare...

Via Benzinga

Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns ↗

July 22, 2024

The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them.

Via InvestorPlace

This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street ↗

July 08, 2024

Investors shouldn't rush to buy the stock based on rosy short-term price targets.

Via The Motley Fool

Exact Sciences schedules second quarter 2024 earnings call

July 08, 2024

From Exact Sciences Corp.

Via Business Wire

The 3 Best Personalized Medicine Stocks to Buy in July 2024 ↗

July 03, 2024

Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies.

Via InvestorPlace

NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

June 26, 2024

Via Benzinga

Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks

June 21, 2024

Mainz Biomed’s ColoAlert Potentially Puts It On A Similar Track As Big Name Cancer Screening Stocks

Via News Direct

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests

June 18, 2024

Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including

Via MarketBeat

Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns ↗

June 13, 2024

Jefferies Financial Group sees these three companies as prime candidates among stocks for double-digit returns.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.